215 related articles for article (PubMed ID: 30036228)
1. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
Nasioudis D; Wilson E; Mastroyannis SA; Sisti G; Haggerty AF; Ko EM; Latif NA
Anticancer Res; 2019 Sep; 39(9):4971-4975. PubMed ID: 31519603
[TBL] [Abstract][Full Text] [Related]
4. Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study.
Bryk S; Katuwal S; Haltia UM; Tapper J; Tapanainen JS; Pukkala E
Gynecol Oncol; 2021 Dec; 163(3):593-597. PubMed ID: 34598830
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study.
Bergfeldt K; Einhorn S; Rosendahl I; Hall P
Acta Oncol; 1995; 34(6):771-7. PubMed ID: 7576744
[TBL] [Abstract][Full Text] [Related]
6. Second primary malignancies among women with uterine sarcoma.
Koivisto-Korander R; Scélo G; Ferro G; Mellemkjaer L; Hemminki K; Weiderpass E; Tamaro S; Pompe-Kirn V; Tracey E; Brewster DH; Kliewer EV; Tonita JM; Kee-Seng C; Jonasson JG; Martos C; Brennan P; Straif K; Pukkala E
Gynecol Oncol; 2012 Jul; 126(1):30-5. PubMed ID: 22487538
[TBL] [Abstract][Full Text] [Related]
7. Second primary cancers in breast cancer patients in Slovenia.
Volk N; Pompe-Kirn V
Cancer Causes Control; 1997 Sep; 8(5):764-70. PubMed ID: 9328199
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study.
Hung MH; Liu CJ; Teng CJ; Hu YW; Yeh CM; Chen SC; Chien SH; Hung YP; Shen CC; Chen TJ; Tzeng CH; Liu CY
PLoS One; 2016; 11(2):e0148597. PubMed ID: 26894298
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
10. Less extensive surgery compared to extensive surgery: survival seems similar in young women with adult ovarian granulosa cell tumor.
Lauszus FF; Petersen AC; Neumann G; Cleemann L; Rosgaard A; Jørgensen A; Vandborg M; Jakobsen A
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():61-6. PubMed ID: 24698496
[TBL] [Abstract][Full Text] [Related]
11. Second primary gynecologic cancers after breast cancer in Turkish women.
Gulhan I; Eser S; Yakut C; Bige O; Ilhan E; Yildirim Y; Saygili U
Int J Gynecol Cancer; 2009 May; 19(4):648-50. PubMed ID: 19509564
[TBL] [Abstract][Full Text] [Related]
12. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
13. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
14. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
Venn A; Watson L; Bruinsma F; Giles G; Healy D
Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
[TBL] [Abstract][Full Text] [Related]
16. A cohort study of 49 933 women with surgically verified endometriosis: Increased incidence of breast cancer below the age of 40.
Saavalainen L; Lassus H; But A; Tiitinen A; Härkki P; Gissler M; Pukkala E; Heikinheimo O
Acta Obstet Gynecol Scand; 2019 Sep; 98(9):1113-1119. PubMed ID: 30883685
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
18. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period.
Lee KD; Chen CY; Huang HJ; Wang TY; Teng D; Huang SH; Lai CH; Chen MC
BMC Cancer; 2015 May; 15():393. PubMed ID: 25957789
[TBL] [Abstract][Full Text] [Related]
20. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
